EGFR and squamous cell carcinoma: Our findings suggest that EGFR mutation testing should be considered even for squamous cell carcinoma patients in East Asian populations, although further studies need to better characterize the prevalence of EGFR mutation testing in East Asian patients with squamous cell lung carcinoma.